• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Serum glycan as a prognostic marker in patients with advanced hepatocellular carcinoma treated with sorafenib.

作者信息

Miyahara Koji, Nouso Kazuhiro, Miyake Yasuhiro, Nakamura Shinichiro, Obi Shuntaro, Amano Maho, Hirose Kazuko, Nishimura Shin-Ichiro, Yamamoto Kazuhide

机构信息

Department of Gastroenterology & Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.

出版信息

Hepatology. 2014 Jan;59(1):355-6. doi: 10.1002/hep.26531. Epub 2013 Nov 19.

DOI:10.1002/hep.26531
PMID:23729393
Abstract
摘要

相似文献

1
Serum glycan as a prognostic marker in patients with advanced hepatocellular carcinoma treated with sorafenib.血清聚糖作为索拉非尼治疗的晚期肝细胞癌患者的预后标志物。
Hepatology. 2014 Jan;59(1):355-6. doi: 10.1002/hep.26531. Epub 2013 Nov 19.
2
Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis.基于糖组学分析鉴定肝细胞癌的新型血清生物标志物。
Hepatology. 2013 Jun;57(6):2314-25. doi: 10.1002/hep.26262. Epub 2013 Apr 26.
3
Des-γ-carboxyprothrombin may be a promising biomarker to determine the therapeutic efficacy of sorafenib for hepatocellular carcinoma.去γ-羧基凝血酶原可能是一种有前途的生物标志物，可用于确定索拉非尼治疗肝细胞癌的疗效。
Dig Dis. 2011;29(3):321-5. doi: 10.1159/000327570. Epub 2011 Aug 9.
4
Identification of unique glycoisoforms of vitamin D-binding protein and haptoglobin as biomarker candidates in hepatocarcinogenesis of STAM mice.鉴定维生素 D 结合蛋白和触珠蛋白的独特糖型作为 STAM 小鼠肝癌发生的生物标志物候选物。
Glycoconj J. 2018 Oct;35(5):467-476. doi: 10.1007/s10719-018-9838-3. Epub 2018 Sep 8.
5
BlotGlycoABCTM, an integrated glycoblotting technique for rapid and large scale clinical glycomics.BlotGlycoABC技术，一种用于快速大规模临床糖组学研究的综合糖印迹技术。
Mol Cell Proteomics. 2008 Feb;7(2):370-7. doi: 10.1074/mcp.M700377-MCP200. Epub 2007 Nov 5.
6
Does the elevation of serum carbohydrate antigen 19-9 level predict poor overall survival in patients with hepatocellular carcinoma?
Tumour Biol. 2015 Nov;36(11):8273-4. doi: 10.1007/s13277-015-4326-x. Epub 2015 Oct 30.
7
ESI-LC-MS Method for Haptoglobin Fucosylation Analysis in Hepatocellular Carcinoma and Liver Cirrhosis.用于肝细胞癌和肝硬化中触珠蛋白岩藻糖基化分析的电喷雾电离液相色谱-质谱联用方法
J Proteome Res. 2015 Dec 4;14(12):5388-95. doi: 10.1021/acs.jproteome.5b00792. Epub 2015 Nov 3.
8
High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib.血清高转化生长因子-β1 水平可预测索拉非尼治疗肝细胞癌患者的预后。
Clin Cancer Res. 2015 Aug 15;21(16):3678-84. doi: 10.1158/1078-0432.CCR-14-1954. Epub 2015 May 14.
9
Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study.血清细胞因子谱预测索拉非尼治疗晚期肝细胞癌患者的生存获益：一项回顾性队列研究。
BMC Cancer. 2017 Dec 19;17(1):870. doi: 10.1186/s12885-017-3889-x.
10
Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent.接受细胞抑制剂治疗的晚期肝细胞癌患者的甲胎蛋白反应
J Clin Oncol. 2009 Dec 20;27(36):e271; author reply e272. doi: 10.1200/JCO.2009.23.8311. Epub 2009 Nov 16.

引用本文的文献

1
N-methyladenosine (mA) RNA methylation regulators are associated with clinical prognosis in hepatocellular carcinoma.N-甲基腺苷（mA）RNA甲基化调节因子与肝细胞癌的临床预后相关。
Transl Cancer Res. 2020 Jan;9(1):323-334. doi: 10.21037/tcr.2019.12.84.
2
Synthetic glycopeptides as a designated standard in focused glycoproteomics to discover serum cancer biomarkers.合成糖肽作为聚焦糖蛋白质组学中发现血清癌症生物标志物的指定标准。
Medchemcomm. 2018 Jun 29;9(8):1351-1358. doi: 10.1039/c8md00162f. eCollection 2018 Aug 1.
3
Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant.
血清异常N-聚糖谱作为活体供肾移植受者早期抗体介导排斥反应的相关标志物
Int J Mol Sci. 2017 Aug 8;18(8):1731. doi: 10.3390/ijms18081731.
4
Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors.血清N-聚糖谱作为生殖细胞肿瘤诊断和预后生物标志物的临床意义
Cancer Med. 2017 Apr;6(4):739-748. doi: 10.1002/cam4.1035. Epub 2017 Mar 20.
5
Recent progress and perspectives on prostate cancer biomarkers.前列腺癌生物标志物的最新进展与展望
Int J Clin Oncol. 2017 Apr;22(2):214-221. doi: 10.1007/s10147-016-1049-y. Epub 2016 Oct 11.
6
DNA hypomethylation upregulates expression of the MGAT3 gene in HepG2 cells and leads to changes in N-glycosylation of secreted glycoproteins.DNA低甲基化上调HepG2细胞中MGAT3基因的表达，并导致分泌型糖蛋白的N-糖基化发生变化。
Sci Rep. 2016 Apr 13;6:24363. doi: 10.1038/srep24363.
7
Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis.大鼠化学诱导性肝细胞癌中聚糖生物合成的见解：糖组学分析
World J Gastroenterol. 2015 May 28;21(20):6167-79. doi: 10.3748/wjg.v21.i20.6167.